Evidence map›Paper›PMID 26559751›Full record

ArticleJournal of human genetics2016

A de novo mosaic mutation of PHEX in a boy with hypophosphatemic rickets.

Chen Weng, Jiao Chen, Li Sun, Zhong-Wei Zhou, Xue Feng, Jun-Hui Sun, Ling-Ping Lu, Ping Yu, Ming Qi

Open access · bronzeAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. A De Novo MosaicJournal of pediatric genetics · 2023
    Article
  3. A NewEndocrine, metabolic & immune disorders drug targets · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Chen WengDepartment of Cell Biology and Medical Genetics, School of Medicine Zhejiang University, Hangzhou, China.
Jiao ChenDepartment of Cell Biology and Medical Genetics, School of Medicine Zhejiang University, Hangzhou, China.
Li SunDepartment of Nephrology and Rheumatology, Children's Hospital of Fudan University, Shanghai, China.
Zhong-Wei ZhouDepartment of Cell Biology and Medical Genetics, School of Medicine Zhejiang University, Hangzhou, China.
Xue FengDepartment of Cell Biology and Medical Genetics, School of Medicine Zhejiang University, Hangzhou, China.
Jun-Hui SunDepartment of Cell Biology and Medical Genetics, School of Medicine Zhejiang University, Hangzhou, China.
Ling-Ping LuDepartment of Cell Biology and Medical Genetics, School of Medicine Zhejiang University, Hangzhou, China.
Ping YuDepartment of Cell Biology and Medical Genetics, School of Medicine Zhejiang University, Hangzhou, China.
Ming QiDepartment of Cell Biology and Medical Genetics, School of Medicine Zhejiang University, Hangzhou, China.
Zhejiang University · CNChildren's Hospital of Fudan University · CNUniversity of Rochester · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

X-linked dominant hypophosphatemic rickets (XLHR), is characterized mainly by renal phosphate wasting with hypophosphatemia, short stature and abnormal bone mineralization. PHEX, located at Xp22.1-p22.2, is the gene causing XLHR. We aim to characterize the pathogenesis of a Chinese boy who is apparently 'heterozygous' in PHEX gene. Direct sequencing showed two peaks: one was a wild-type 'G' and the other was one base substitution to 'A', though the patient was a male. TA clone assay clearly showed each sequences and the ratios. The mutation effect was predicted via bioinformatics and validated by exon-trapping assay. Real-time PCR was applied to determine the copy number of PHEX. TA clone assay showed the frequency of normal (G) to mutant allele (A) as 19:13. Normal karyotype and real-time PCR results indicate the normal copy number of PHEX. This splice site mutation leads to 4 bp of exon 18 skipping out causing frame shift p.Gly590Glufs*28 that ends up with a loss of active site and Zn(2+)-binding site of PHEX, which probably interfere with renal phosphate reabsorption and bone mineralization. In conclusion, mutation at conserved splice acceptor site resulted in aberrant splicing, ending up with a damaged protein product. This novel mutation is de novo in mosaic pattern that may be induced during early postzygotic period. Taking mosaic somatic mutation of PHEX into consideration is strongly suggested in genetic counseling and etiology research for XLHR.

Indexed as

MosaicismMutationChildHumansKaryotypingMalePHEX Phosphate Regulating Neutral EndopeptidaseReal-Time Polymerase Chain ReactionRickets, HypophosphatemicPHEX Phosphate Regulating Neutral EndopeptidasePHEX protein, human

Identifiers

PMID26559751
OpenAlexW2215759147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.